跳至主要内容
临床试验/CTRI/2025/02/080427
CTRI/2025/02/080427尚未招募2 期

Single centric non-randomized open clinical trial phase II in uratha pitha vatham (Essential Hypertension)with the Siddha medicine Seenthil chooranam among patients attending OPD at Government Siddha Medical College, Chennai

M Sharmila1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2025年2月20日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
The Patients who are classified as prehypertension stage will be managed to normal stage. The patients who are classified as stage I hypertension will be managed to prehypertension stage or normal stage.

研究概览

简要总结

Hypertension is a common disorder in the past middle age, doubling the risk of cardiovascular diseases. Seenthil chooranam mentioned in Agastiyar paripooranam 400 is indicated in the treatment of uratha pitha vatham(Hypertension). The components of the medicine include Tinospora cordifolia, Eclipta alba, Earthworm. The constituents of the medicine possess anti-hypertensive , antioxidant and diuretic properties. The aim of the study is the clinical management of uratha pitha vatham(Hypertension )with the Siddha medicine Seenthil chooranam.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
30.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patients with Pre hypertension stage and Stage I hypertension according to JNC 8 guidelines will be included.

排除标准

  • Age above 60 years Stage II hypertension Vulnerable population and patients with associated serious systemic illness.

结局指标

主要结局

The Patients who are classified as prehypertension stage will be managed to normal stage. The patients who are classified as stage I hypertension will be managed to prehypertension stage or normal stage.

时间窗: 48 days

次要结局

  • The reduction in the lipid profile(48 days)

研究者

发起方
M Sharmila
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

M Sharmila

Government Siddha Medical College, Arumbakkam, Chennai

研究点 (1)

Loading locations...

相似试验